Cryptocurrency & Digital Assets

Securities processors have filed a plan to extend trading to nearly 24 hours a day, a move set to transform Wall Street but posing huge tech hurdles.

Fortune 500 giant ARKO Corp. plans to take its petroleum wholesale business public, a strategic split aimed at unlocking value and focusing growth.

A landmark executive order to reschedule cannabis and create a Medicare CBD program could unleash a $30B market and redefine the economics of the industry.

NDT Pharmaceuticals' subsidiary launches PurrGuard and Dog Gone Odor, leveraging antimicrobial tech to disrupt the multi-billion-dollar pet hygiene industry.

A landmark executive order reclassifying cannabis is set to unleash a wave of biopharma innovation, validating science-first firms like Avicanna.

A strategic partnership aims to merge respiratory rentals with innovative hygiene products, promising better compliance and comfort for millions of CPAP users.

Tech billionaire and commercial astronaut Jared Isaacman is the new NASA chief. Can his entrepreneurial vision and private space experience reshape the agency?

One Times Square now offers limited-time tickets for an up-close look at the famous New Year's Eve Ball before the building's grand 2026 reopening.

President Trump's order eases marijuana rules, but a new law threatens to dismantle the $28B hemp industry, creating unprecedented regulatory chaos.

Titan Mining's new funding aims to end a 70-year U.S. graphite production gap, a critical move for the nation's EV and energy independence goals.

A historic U.S. executive order reclassifies cannabis, opening the door for pharmaceutical products. One Canadian firm is already years ahead of the curve.

With a massive capital raise and rapid microreactor progress, NANO Nuclear is positioning itself to power the AI boom and lead a new nuclear renaissance.

Ottawa's National Gallery unveils new exhibits and family fun with free admission for youth, blending high art with interactive holiday experiences.

An executive order accelerates moving cannabis to Schedule III, promising massive tax breaks for businesses but leaving advocates wanting more federal reform.

President Trump’s historic order to reschedule cannabis unlocks a new era, promising massive tax relief, medical research, and a path toward normalization.

For the first time, Medicare and Medicaid will cover CBD products for senior cancer patients, a landmark decision with massive implications for patients and markets.

A monumental shift in U.S. drug policy as cannabis is rescheduled. See what this means for Verano, Wall Street, and the future of the industry.

A new national scholarship champions medical integrity, yet its founder recently settled a major False Claims Act case, raising complex questions.

Backcast Partners elevates three key members, revealing a strategy that links internal talent development to its rapid expansion in middle-market private credit.

The Channel Partners 2026 conference will address the rapid pace of AI and market shifts with its 'Channel Velocity' theme and a Robert Irvine keynote.